Skip to main content
SpringerLink
Log in

A Feasibility Study of Sentinel Lymph Node Biopsy in Endometrial Cancer Using Technetium 99m Nanocolloid

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

To study the feasibility of sentinel node biopsy in early-stage endometrial cancer and to analyse the detection rate of sentinel lymph node (SLN) using preoperative cervical injection of Tc99m nanocolloid. Thirty-five patients with preoperative histological diagnosis of endometrial cancer without any extrauterine involvement on imaging were included in the study. Sentinel node mapping was done by cervical injection of Tc99m nanocolloid on the evening before surgery. Scintigraphic images were taken using gamma camera. Intraoperatively, nodes showing radioactivity were detected using hand-held gamma probe, dissected out separately and labelled as sentinel lymph nodes. Detection rate was calculated and analysed with respect to various parameters. Sentinel lymph node biopsy (SLNB) is feasible in endometrial cancer using cervical injection of Tc99m nanocolloid. SLN detection was done in 33 (94.3%) out of 35 patients. Bilateral detection was feasible in 19 patients (54.3%) with detection in left and right hemipelvis being 74.3%. Detection rate of SLN was 93.7% in endometrioid adenocarcinoma. Sentinel node was detected in all the patients with non-endometrioid histology. The SLNB using cervical injection of Tc99m nanocolloid is feasible in endometrial cancer. It is a safe and easily reproducible technique with good detection rate and high sensitivity. Stage of the tumour, grade and myometrial invasion do not seem to have an influence on sentinel node detection. Cervical involvement, enlarged lymph nodes and obstructed lymphatics can affect sentinel node mapping adversely.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011 Mar) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  Google Scholar 

  2. Boente MP, Yordan EL, McIntosh DG, Grendys EC, Orandi YA, Davies S et al (1993 Dec) Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 51(3):316–322

    Article  CAS  Google Scholar 

  3. Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 18(2):269–73

  4. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov 1;95 Suppl 1:S105–43

  5. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, Keeney GL, Mariani A, Podratz KC (2012) Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127(1):5–10

    Article  CAS  Google Scholar 

  6. Ballester M, Dubernard G, L??curu F, Heitz D, Mathevet P, Marret H, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;

  7. Fay Ferkle N, Nicole McMillian P, Jillian Scavone M, Dorigo O, Eifel PJ, Fisher CM, et al. NCCN Guidelines Index Uterine Neoplasms TOC Discussion NCCN Guidelines Version 2.2016 Panel Members Uterine Neoplasms MD/Liaison Dana-Farber/Brigham and Women’s Cancer Center

  8. Wahid FN, Malkan AD, Pappo A, Wright BB, Adefeyisan S, Sandoval JA (2014) Severe anaphylactic shock due to methylene blue dye. J Pediatr Surg Case Reports 2(3):117–118

    Article  Google Scholar 

  9. M M, E S. Detection of sentinel lymph node in endometrial cancer by hysteroscopic peritumoral injection on 99mTc labeled albumin nanocolloid, preliminary results. Eur J Nucl Med Mol Imaging. 2007;34:S203

  10. Kang S, Yoo HJ, Hwang JH, Lim M-C, Seo S-S, Park S-Y (2011) Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol 123:522–527

    Article  Google Scholar 

  11. Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol [Internet]. Elsevier; 2004 Feb 1 [cited 2016 Aug 27];92(2):669–74

  12. Rossi EC, Ivanova A, Boggess JF. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study. Gynecol Oncol [Internet]. Elsevier Inc.; 2012;124(1):78–82. Available from: https://doi.org/10.1016/j.ygyno.2012.04.010

  13. Holloway RW, Bravo RA, Rakowski JA, James JA, Jeppson CN, Ingersoll SB, Ahmad S (2012 Jul 31) Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: a comparison of colorimetric and fluorescence imaging. Gynecol Oncol 126(1):25–29

    Article  Google Scholar 

  14. Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. Articles A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging ( FIRES trial ): a multicentre , prospective , cohort study. Lancet Oncol [Internet]. Elsevier Ltd; 2017;2045(17):1–9

  15. How J, Lau S, Press J, Ferenczy A, Pelmus M, Stern J, Probst S, Brin S, Drummond N, Gotlieb W (2012 Nov 30) Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: a prospective study. Gynecol Oncol 127(2):332–337

    Article  Google Scholar 

  16. Kim CH, Soslow RA, Park KJ, Barber EL, Khoury-Collado F, Barlin JN, Sonoda Y, Hensley ML, Barakat RR, Abu-Rustum NR (2013 Jun) Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society 23(5):964–970

    Article  Google Scholar 

  17. Buda A, Crivellaro C, Elisei F, Martino G Di, Guerra L, Ponti E De, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer 99m Tc and/or blue dye. 2016;2183–91

Download references

Author information

Authors and Affiliations

  1. Department of OBG, GKNM hospital, Coimbatore, India

    Vidhyalakshmi S.

  2. Department of Nuclear medicine, GKNM hospital, Coimbatore, India

    Anirudhan

  3. Department of Oncology, GKNM hospital, Coimbatore, India

    Latha Balasubramani

Authors
  1. Vidhyalakshmi S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anirudhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Latha Balasubramani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Vidhyalakshmi S., Anirudhan or Latha Balasubramani.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

S., V., Anirudhan & Balasubramani, L. A Feasibility Study of Sentinel Lymph Node Biopsy in Endometrial Cancer Using Technetium 99m Nanocolloid. Indian J Surg Oncol 11, 699–704 (2020). https://doi.org/10.1007/s13193-019-01020-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-019-01020-6

Keywords

Search

Navigation